2026 Peter Jones: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Best Scientists	183	549	507	59	55	2343	142003
Medicine	186	295	268	35	33	1820	140160

Research.com Recognitions

2026 - Research.com Medicine in United Kingdom Leader Award
2025 - Research.com Best Scientists Award
2025 - Research.com Medicine in United Kingdom Leader Award
2023 - Research.com Medicine in United Kingdom Leader Award

Overview

Peter Jones is affiliated with the University of Cambridge in the United Kingdom and has an extensive publication record spanning Medicine and Psychology. Their research is concentrated primarily in the fields of Psychiatry and Mental Health, Clinical Psychology, and Experimental and Cognitive Psychology, along with related areas such as Social Psychology and Pharmacology.

The main topics of their work cover various aspects of mental health, including schizophrenia research and treatment, mental health treatment and access, and broader mental health research topics. Their research also touches on bipolar disorder and treatment, tryptophan and brain disorders, child and adolescent psychosocial and emotional development, and the impact of COVID-19 on mental health.

Among their recent papers are:

Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies (2021), published in Molecular Psychiatry
Brain charts for the human lifespan (2022), published in Nature
The social determinants of mental health and disorder: evidence, prevention and recommendations (2024), published in World Psychiatry
The Lancet Psychiatry Commission on youth mental health (2024), published in The Lancet Psychiatry
Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts (2021), published in Molecular Psychiatry

Frequent co-authors collaborating with Peter Jones include Stephen M. Stahl, Sepehr Hafizi, Veronika Dobler, Liliana Galindo, and George Griffiths.

Their work has been consistently published in journals such as Psychological Medicine, Schizophrenia Bulletin, bioRxiv (Cold Spring Harbor Laboratory), Molecular Psychiatry, and Schizophrenia Research.

Peter Jones has also contributed to the academic literature through books, including a publication with Springer Science+Business Media titled "Neuroinflammation and Schizophrenia" released in 2020.

Best Publications

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

Theresa H. M. Moore;Stanley Zammit;Stanley Zammit;Anne Lingford-Hughes;Thomas R. E. Barnes

2939
Citations
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* trial)

Peter H Jones;Michael H Davidson;Evan A Stein;Harold E Bays

2100
Citations
Association Between Duration of Untreated Psychosis and Outcome in Cohorts of First-Episode Patients: A Systematic Review

Max Marshall;Shon Lewis;Austin Lockwood;Richard Drake

2047
Citations
Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men: A Randomized, Controlled Trial

Robert Ross;Damon Dagnone;Peter J.H. Jones;Heidi Smith

2011
Citations
CHILD DEVELOPMENTAL RISK-FACTORS FOR ADULT SCHIZOPHRENIA IN THE BRITISH 1946 BIRTH COHORT

P Jones;B Rodgers;R Murray;M Marmot

1816
Citations
Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and Fluvastatin in patients with hypercholesterolemia (The CURVES Study)

Peter Jones;Stephanie Kafonek;Irene Laurora;Donald Hunninghake

1614
Citations
Obstetric Complications and Schizophrenia: Historical and Meta-Analytic Review

Mary Cannon;Peter B. Jones;Robin M. Murray

1575
Citations
Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)

Peter B. Jones;Thomas R. E. Barnes;Linda Davies;Graham Dunn

1529
Citations
Efficacy and Safety of Plant Stanols and Sterols in the Management of Blood Cholesterol Levels

Martijn B. Katan;Scott M. Grundy;Peter Jones;Malcolm Law

1347
Citations
The valuation of reliability for personal travel

John Bates;John Polak;Peter M. Jones;Andrew J. Cook

1193
Citations
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

Dmitri Tkachev;Michael L Mimmack;Michael L Mimmack;Margaret M Ryan;Margaret M Ryan;Matt Wayland

1054
Citations
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

Marta Di Forti;Marta Di Forti;Marta Di Forti;Diego Quattrone;Diego Quattrone;Diego Quattrone;Tom P. Freeman;Giada Tripoli

858
Citations
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Golam M Khandaker;Golam M Khandaker;Golam M Khandaker;Lesley Cousins;Lesley Cousins;Lesley Cousins;Julia Deakin;Julia Deakin;Julia Deakin;Belinda R Lennox

858
Citations
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

Terry A. Jacobson;Matthew K. Ito;Kevin C. Maki;Carl E. Orringer

830
Citations
Dietary phytosterols: A review of metabolism, benefits and side effects

W.H Ling;P.J.H Jones

821
Citations
Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life: A Population-Based Longitudinal Study

Golam M. Khandaker;Rebecca M. Pearson;Stanley Zammit;Stanley Zammit;Glyn Lewis;Glyn Lewis

811
Citations
Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial.

Peter Sheehan;Peter Jones;Antonella Caselli;John M. Giurini

798
Citations
Adult mental health disorders and their age at onset

P. B. Jones

735
Citations
The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia.

J M Haro;S A Kamath;S Ochoa;D Novick

728
Citations
Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men

Robert Ross;Damon Dagnone;Peter J.H. Jones;Heidi Smith

560
Citations

Frequent Co-Authors

Robin M. Murray King's College London

Daphne Comfort University of Gloucestershire

Craig Morgan King's College London

Paola Dazzan King's College London

David Hillier University of Strathclyde

Richard C. Strange Keele University

Anthony A. Fryer Keele University

Kevin Morgan University of Nottingham

Graham K. Murray University of Cambridge

James B. Kirkbride University College London

External Links

Personal website of Peter Jones

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Studying Medicine in the USA can lead to a diverse range of career options. Aside from a traditional MD degree, aspiring healthcare professionals are increasingly turning to online programs to advance their careers, enhance flexibility, and make education more affordable.

For those interested in healthcare management, affordable mha online programs offer a pathway to leadership roles in hospitals and clinics. Nurses aiming to reach the highest clinical levels should explore the best dnp programs online to become nurse practitioners or clinical leaders.

Pharmacists can advance through pharm d online programs, which combine clinical knowledge with the flexibility of distance learning. For those interested in the technological side of healthcare, health information technology online degree options are a great way to enter the growing field of health informatics.

These online degree pathways support various career goals in healthcare, allowing students to pursue specialized roles while balancing work and study.